Refael Elisha Meir ben Devorah Cohen

I realize that I just wrote about infamous cancer doctor Stanislaw Burzynski yesterday. (Note how I refuse to call him an "oncologist," mainly because he isn't one, having never completed an oncology fellowship—or even an internal medicine residency, the usual prerequisite to do an oncology fellowship.) However, there's a bit more that I wanted to touch on before moving on to other topics. What brought this on was a Google Alert that appeared in my in box yesterday relevant to yesterday's post. You might recall that yesterday I mentioned a campaign by the Alliance for Natural Health USA (ANH-…
The year 2013 finished with serious setbacks for Stanislaw Burzynski and his unproven cancer treatment that he dubbed "antineoplastons" (ANPs) way back in the early 1970s. As you might recall, in November, two things happened. First, the FDA released its initial reports on its inspection of the Burzynski Clinic and Burzynski Research Institute (BRI) carried out from January to March 2013. They were damning in the extreme, pointing out the shoddy operating methods of the institutional review board (IRB) used by the BRI to approve and oversee Burzynski's "clinical trials" (and I use the term…